Sol-Gel Technologies Ltd.
NASDAQ:SLGLBiotechnology
+$1.19 today
- Market cap
- $174.70M
- Beta
- 1.13
- P/E (TTM)
- -194.1
- EPS (TTM)
- -$0.37
Volume 0.03M
Average 0.04M
SLGL Total Current Liabilities
All obligations due within one year.
Sol-Gel Technologies Ltd.NASDAQ: SLGL
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities rises 38.0% from a year ago
Total current liabilities stood at $6.31M at the end of Q1 FY2026, up 38.0% from a year earlier and up 2.3% from the prior quarter. Over 3 fiscal years it compounded at +22.8% a year.
Context
- Total current liabilities amounted to 10.8% of total assets at the end of Q1 FY2026, down 6.1 pp from a year earlier.
- Total current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +38.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 6.17M USD
- Year-over-year change
- +16.8%
- 4-year CAGR
- -14.8%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.17M | +16.8% |
| FY2024 | 2024-12-31 | 5.29M | +16.9% |
| FY2023 | 2023-12-31 | 4.52M | +35.8% |
| FY2022 | 2022-12-31 | 3.33M | -71.5% |
| FY2021 | 2021-12-31 | 11.69M | — |
Total Current Liabilities vs competitors
How SLGL compares with its peers on the latest reported figures
- SLGL's Mar 2026 total current liabilities of $6.31M is the 9th highest of the 10 companies compared; the peer median is $10.56M.
- Its year-over-year change of +38.0% is the 5th highest of 10, against a peer median of -18.3%.
- Total current liabilities amounts to 10.8% of total assets for SLGL, versus a peer median of 13.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $95.94M | +73.0% | -3.9% | 44.0% | |
| Mar 2026 | $35.24M | -28.7% | -13.6% | 13.9% | |
| Mar 2026 | $15.75M | +69.2% | +5.8% | 7.0% | |
| Dec 2025 | $11.21M | +52.5% | +18.9% | 97.5% | |
| Mar 2026 | $10.56M | +92.3% | +49.2% | 3.9% | |
| Mar 2026 | $10.36M | -63.3% | -11.9% | 5.1% | |
| Sep 2025 | $8.06M | -19.8% | +89.6% | 173.5% | |
| Mar 2026 | $6.73M | -37.5% | -8.0% | 31.1% | |
| Mar 2026 | $6.31M | +38.0% | +22.8% | 10.8% | |
| Mar 2026 | $3.55M | -18.3% | +15.4% | 6.7% | |
| Peer median (excluding SLGL) | $10.56M | -18.3% | +5.8% | 13.9% | |
Competitors are the stored peer set for SLGL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 20.09M | 12.45M | 7.51M | 19.49M | 11.03M |
| Short-term Investments | 23.16M | 21.18M | 30.48M | 4.44M | 12.97M |
| Net Receivables | 13.07M | 7.92M | 377K | 3.6M | 1.97M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 2.79M | 3.77M | 1M |
| Total Current Assets | 57.11M | 43.06M | 41.17M | 31.3M | 26.97M |
| Property, Plant & Equipment (Net) | 2.55M | 1.54M | 2.16M | 1.63M | 1.17M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 8.7M | 1.29M | 1.28M | 2.32M | 1.32M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 830K | 749K | 681K | 608K | 455K |
| Total Non-current Assets | 12.08M | 3.57M | 4.12M | 4.55M | 2.95M |
| Total Assets | 69.19M | 46.63M | 45.29M | 35.85M | 29.92M |
| Account Payables | 766K | 251K | 154K | 1.27M | 735K |
| Short-term Debt | 0 | 0 | 0 | 0 | 495K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 4.49M |
| Total Current Liabilities | 11.69M | 3.33M | 4.52M | 5.29M | 6.17M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.09M | 1.03M | 915K | 833K | 439K |
| Total Non-current Liabilities | 1.9M | 1.09M | 2.12M | 1.71M | 935K |
| Total Liabilities | 13.6M | 4.42M | 6.64M | 7M | 7.11M |
| Common Stock | 638K | 638K | 774K | 774K | 774K |
| Retained Earnings | (178.14M) | (193.07M) | (220.3M) | (230.88M) | (237.01M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 55.59M | 42.21M | 38.64M | 28.85M | 22.81M |
| Total Debt | 1.59M | 772K | 1.65M | 1.31M | 991K |
| Net Debt | (18.49M) | (11.68M) | (5.86M) | (18.18M) | (10.04M) |
Sol-Gel Technologies Ltd.
NASDAQ:SLGL
Intrinsic Alpha fair value
Locked
Current Price
$53.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.